Small Cap Stocks To Buy Based on Artificial Intelligence: Returns up to 72.62% in 1 Month

Small Cap Stocks To Buy

The Small Cap Package includes recommendations by the I Know First algorithm for small cap stocks to buy with a market capitalization of less than $1 billion:

  • Top 10 Small Cap stocks to buy for the long position
  • Top 10 Small Cap stocks to buy for the short position


Package Name: Small Cap Stocks
Recommended Positions: Long & Short
Forecast Length: 1 Month (03/22/2019 – 04/22/2019)
I Know First Average: 6.25% (Long) & 11.61% (Short)
Small Cap Stocks To Buy

During the 1 Month forecast, the algorithm had predicted high returns for those seeking stock advice. The best performance in the short position came from AKAO which registered a return of 72.62%. For the long positions the largest growth was registered by TGB with a return of 20.06%, during the same period. The package itself, had an overall average return of 6.25%, in the long position, providing a premium of 4.39% over the SP500’s return of 1.86%. With regards to the short position, the package had an overall average return of 11.61%, providing investors with a premium of 9.75% over S&P500’s return of 1.86%. The I Know First’s Stock Market Algorithm accurately forecasted 6 out of 10 stocks, for the long position, and 7 out of 10 stocks, for the short position for this 1 Month forecasted period.

Achaogen, Inc., incorporated on November 26, 2002, is a late-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The Company is involved in researching and developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae (CRE). Plazomicin is an intravenous aminoglycoside antibiotic. The Company has developed plazomicin by chemically modifying sisomicin, a naturally occurring aminoglycoside, in order to overcome common aminoglycoside resistance mechanisms.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

How to interpret this diagram:

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.